The Efficacy of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis

被引:4
|
作者
Choi, Hee Eun [1 ]
Kim, Tae Hoon [1 ]
Jang, Ji Hoon [2 ]
Jang, Hang-Jea [2 ]
Yi, Jisook [3 ]
Jung, So Young [4 ]
Kim, Dae-Wook [5 ]
Lee, Jae Ha [2 ]
机构
[1] Inje Univ Coll Med, Haeundae Paik Hosp, Dept Phys Med & Rehabil, Busan 48108, South Korea
[2] Inje Univ Coll Med, Haeundae Paik Hosp, Dept Internal Med, Div Pulmonol & Crit Care Med, Busan 48108, South Korea
[3] Inje Univ Coll Med, Haeundae Paik Hosp, Dept Radiol, Busan 48108, South Korea
[4] Inje Univ Coll Med, Haeundae Paik Hosp, Div Dermatol, Busan 48108, South Korea
[5] Inje Univ Coll Med, Haeundae Paik Hosp, Dept Orthoped Surg, Busan 48108, South Korea
来源
LIFE-BASEL | 2023年 / 13卷 / 02期
关键词
idiopathic pulmonary fibrosis; pulmonary rehabilitation; clinical efficacy; functional performance; exercise-related oxygen saturation; health-related quality of life; THORACIC SOCIETY; LUNG-DISEASE; UPDATE; CAPACITY; TRIAL;
D O I
10.3390/life13020403
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: This study evaluated the efficacy and safety of pulmonary rehabilitation (PR) on functional performance, exercise-related oxygen saturation, and health-related quality of life among patients with idiopathic pulmonary fibrosis (IPF). Methods: A total of 25 patients with IPF (13 in the PR group and 12 in the non-PR group) were enrolled between August 2019 and October 2021 at Haeundae-Paik Hospital in the Republic of Korea. A cardiopulmonary exercise test (CPET), six-minute walk test (6MWT), pulmonary function test (PFT), Saint George's Respiratory Questionnaire (SGRQ), muscle strength test, and bioelectrical impedance analysis were performed in each group at baseline and after eight weeks of PR. Results: The mean age was 68 years of age and most subjects were male. Baseline characteristics were similar between the two groups. The distance during 6MWT after PR was significantly improved in the PR group (inter-group p-value = 0.002). VO(2)max and VE/VCO2 slopes showed a significant difference after eight weeks only in the PR group, but the rate of change did not differ significantly from the non-PR group. Total skeletal muscle mass, PFT variables, and SGRQ scores did not differ significantly between the groups. Conclusions: PR improved exercise capacity, as measured using CPET and 6 MWT. Further studies in larger samples are needed to evaluate the long-term efficacy of PR in IPF patients.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The role of pulmonary rehabilitation in idiopathic pulmonary fibrosis: An overview of systematic reviews
    Song, Shangyue
    Feng, Zhenzhen
    Liu, Wenrui
    Li, Jiansheng
    PLOS ONE, 2023, 18 (12):
  • [42] EFFECTS OF IN-PATIENT PULMONARY REHABILITATION FOR ADVANCED IDIOPATHIC PULMONARY FIBROSIS
    Mishima, Takuya
    Ogawa, Tomoya
    Watanabe, Fumiko
    Hirasawa, Jun
    Furukawa, Takuro
    Tanaka, Yuko
    Shingai, Kazuya
    Nagae, Yusuke
    Taniguchi, Hiroyuki
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Kataoka, Kensuke
    Matsuda, Toshiaki
    Yokoyama, Toshiki
    RESPIROLOGY, 2013, 18 : 136 - 136
  • [43] Effect of Pulmonary Rehabilitation Program on Exercise Tolerance and Functional Capacity in Patients with Idiopathic Pulmonary Fibrosis
    Vainshelboim, Baruch
    Oliveira, Jose
    Yohoshua, Liora
    Wais, Israela
    Kramer, Mordechai R.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2013, 45 (05): : 543 - 543
  • [44] Current status of pulmonary rehabilitation and impact on prognosis of patients with idiopathic pulmonary fibrosis in South Korea
    Nam, Jung Hyun
    Kim, Kyung Joo
    Rhee, Chin Kook
    Choi, Joon Young
    Jo, Yong Suk
    JOURNAL OF THORACIC DISEASE, 2024, 16 (12)
  • [45] Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
    Kozu, Ryo
    Senjyu, Hideaki
    Jenkins, Sue C.
    Mukae, Hiroshi
    Sakamoto, Noriho
    Kohno, Shigeru
    RESPIRATION, 2011, 81 (03) : 196 - 205
  • [46] Mycobacterial Pulmonary Infections in Patients with Idiopathic Pulmonary Fibrosis
    Park, Sung-Woo
    Song, Jin Woo
    Shim, Tae Sun
    Park, Moo-Suk
    Lee, Hong-Lyeol
    Uh, Soo-Taek
    Park, Choon-Sik
    Kim, Dong Soon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (08) : 896 - 900
  • [47] Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis
    Aubry, MC
    Myers, JL
    Douglas, WW
    Tazelaar, HD
    Stephens, TLW
    Hartman, TE
    Deschamps, C
    Pankratz, VS
    MAYO CLINIC PROCEEDINGS, 2002, 77 (08) : 763 - 770
  • [48] OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND PULMONARY HYPERTENSION
    Collins, Ashley
    King, Christopher
    Shlobin, Oksana
    Nathan, Steven
    CHEST, 2020, 158 (04) : 1071A - 1072A
  • [49] Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
    Takeda, Yoshito
    Tsujino, Kazuyuki
    Kijima, Takashi
    Kumanogoh, Atsushi
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 361 - 370
  • [50] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
    Richeldi, Luca
    du Bois, Roland M.
    Raghu, Ganesh
    Azuma, Arata
    Brown, Kevin K.
    Costabel, Ulrich
    Cottin, Vincent
    Flaherty, Kevin R.
    Hansell, David M.
    Inoue, Yoshikazu
    Kim, Dong Soon
    Kolb, Martin
    Nicholson, Andrew G.
    Noble, Paul W.
    Selman, Moises
    Taniguchi, Hiroyuki
    Brun, Michele
    Le Maulf, Florence
    Girard, Mannaig
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Disse, Bernd
    Collard, Harold R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22): : 2071 - 2082